|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"shih c"
Showing items 41-90 of 117 (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2021-07-03T03:34:00Z |
Feedback regulation of IFN-α/β signaling by Axl receptor tyrosine kinase modulates HBV immunity
|
Huang M.-T.; Liu W.-L.; Lu C.-W.; Huang J.-J.; Chuang H.-L.; Huang Y.-T.; Horng J.-H.; Liu P.; Han D.-S.; Chiang B.-L.; Shih C.; PEI-JER CHEN; Chen D.-S. |
| 臺大學術典藏 |
2021-07-02T03:41:30Z |
Feedback regulation of IFN-α/β signaling by Axl receptor tyrosine kinase modulates HBV immunity
|
Huang M.-T.; Liu W.-L.; Lu C.-W.; Huang J.-J.; Chuang H.-L.; Huang Y.-T.; Horng J.-H.; Liu P.; Han D.-S.; BOR-LUEN CHIANG; Shih C.; Chen P.-J.; Chen D.-S. |
| 臺大學術典藏 |
2021-07-02T03:41:11Z |
A Polysaccharide Purified From Ganoderma lucidum Acts as a Potent Mucosal Adjuvant That Promotes Protective Immunity Against the Lethal Challenge With Enterovirus A71
|
Lin Y.-L.; Shih C.; Cheng P.-Y.; Chin C.-L.; Liou A.-T.; Lee P.-Y.; BOR-LUEN CHIANG |
| 臺大學術典藏 |
2021-05-20T02:15:31Z |
Cellular Extract Preparation for Superoxide Dismutase (SOD) Activity Assay
|
Kuo W., Huang C., Shih C. and?Jinn T.L; Kuo W.; Huang C.; Shih C.; Jinn T.L |
| 國家衛生研究院 |
2021-05-19 |
Discovery and synthesis of a pyrimidine-based aurora kinase inhibitor to reduce levels of MYC oncoproteins
|
Chi, YH;Yeh, TK;Ke, YY;Lin, WH;Tsai, CH;Wang, WP;Chen, YT;Su, YC;Wang, PC;Chen, YF;Wu, ZW;Yeh, JY;Hung, MC;Wu, MH;Wang, JY;Chen, CP;Song, JS;Shih, C;Chen, CT;Chang, CP |
| 國家衛生研究院 |
2021-04-01 |
Heterocyclic compounds and use thereof
|
Shih, C;Shia, KS;Wu, CH;Choi, Ming Chen;Song, JS;Wang, Y |
| 國家衛生研究院 |
2021-01-05 |
Heterocyclic compounds and use thereof
|
Shia, KS;Wu, CH;Chou, MC;Song, JS;Wang, Y;Shih, C |
| 國家衛生研究院 |
2020-12-23 |
Aminothiazole compounds as protein kinase inhibitors
|
Shih, C;Jiaang, WT;Tsai, HJ |
| 臺大學術典藏 |
2020-12-09T09:01:08Z |
Feedback regulation of IFN-α/β signaling by Axl receptor tyrosine kinase modulates HBV immunity
|
Huang M.-T.; Liu W.-L.; CHUN-WEI LU; Huang J.-J.; Chuang H.-L.; Huang Y.-T.; Horng J.-H.; Liu P.; Han D.-S.; Chiang B.-L.; Shih C.; Chen P.-J.; Chen D.-S. |
| 臺大學術典藏 |
2020-11-03T15:39:38Z |
Thyroid cancer incidentally found in radical surgery for laryngeal/hypopharyngeal cancer
|
Shih C; CHENG-PING WANG; Lou P.-J; Hu Y.-L; Yang T.-L; Ko J.-Y; Lee S.-Y. |
| 臺大學術典藏 |
2020-11-03T15:39:37Z |
Recurrent Nasopharyngeal Carcinoma Presenting as a Positron Emission Tomography False-negative Scan
|
CHENG-PING WANG; Ting L.-L; Hsiao J.-K.; Ko J.-Y; Shih C |
| 臺大學術典藏 |
2020-10-27T12:04:38Z |
Thyroid cancer incidentally found in radical surgery for laryngeal/hypopharyngeal cancer
|
Yang T.-L; Hu Y.-L; Shih C;Wang C.-P;Pei-Jen Lou;Hu Y.-L;Yang T.-L;Ko J.-Y;Lee S.-Y.; Shih C; Wang C.-P; PEI-JEN LOU; Ko J.-Y; Lee S.-Y. |
| 國家衛生研究院 |
2020-10-08 |
Comparative study between deep learning and QSAR classifications for TNBC inhibitors and novel GPCR agonist discovery
|
Tsou, LK;Yeh, SH;Ueng, SH;Chang, CP;Song, JS;Wu, MH;Chang, HF;Chen, SR;Shih, C;Chen, CT;Ke, YY |
| 國家衛生研究院 |
2020-08 |
BPR6K609: An Aurora kinase inhibitor targeting small cell lung cancer with MYC amplification
|
Chi, YH;Chang, CP;Ke, YY;Lin, WH;Wang, WP;Tsai, CH;Chen, YT;Su, YJ;Hung, MC;Wu, ZW;Wu, MH;Yeh, TK;Chen, CP;Song, JS;Chen, CT;Shih, C |
| 臺大學術典藏 |
2020-06-11T06:35:14Z |
A Full-Wave Analysis of Microstrip Lines by Variational Conformal Mapping Technique
|
Jeng, S.-K.; Chen, C.H.; SHYH-KANG JENG; Wu, R.-B.; Shih, C.; Shih, C.;Wu, R.-B.;Jeng, S.-K.;Chen, C.H. |
| 國家衛生研究院 |
2020-03-24 |
Tetrahydroisoquinolines for use as MOR/NOP dual agonists
|
Ueng, SH;Yeh, SH;Chao, PK;Shih, C |
| 國家衛生研究院 |
2020-03-10 |
Benzimidazole compounds and use thereof for treating alzheimer's disease or huntington's disease
|
Chen, CH;Shih, C;Chen, CT;Wang, HJ;Huang, KF |
| 臺大學術典藏 |
2020-03-06T03:43:11Z |
Communicating and prioritizing science and technology policy using AHP
|
Wu Y.-C.; BOU-WEN LIN; Shih C.; CHUNG-JEN CHEN |
| 國家衛生研究院 |
2020-02-10 |
Unique sulfur-aromatic interactions contribute to the binding of potent imidazothiazole indoleamine 2,3-Dioxygenase inhibitors
|
Peng, YH;Liao, FY;Tseng, CT;Kuppusamy, R;Li, AS;Chen, CH;Fan, YS;Wang, SY;Wu, MH;Hsueh, CC;Chang, JY;Lee, LC;Shih, C;Shia, KS;Yeh, TK;Hung, MS;Kuo, CC;Song, JS;Wu, SY;Ueng, SH |
| 臺大學術典藏 |
2020-02-07T03:43:45Z |
Comparison of ultrasound and electromagnetic field effects on osteoblast growth
|
Kuan-Jung Li J.;Cheng-An Lin J.;Liu H.-C.;Jui-Sheng Sun;Ruaan R.-C.;Shih C.;Hong-Shong Chang W.; Kuan-Jung Li J.; Cheng-An Lin J.; Liu H.-C.; JUI-SHENG SUN; Ruaan R.-C.; Shih C.; Hong-Shong Chang W. |
| 國家衛生研究院 |
2020-01-28 |
Thiazolidinone compounds and use thereof
|
Shih, C;Ueng, SH;Yeh, SH;Lin, Shu Yu;Loh, H |
| 國立成功大學 |
2020 |
BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine
|
Chao, P.-K.;Chang, H.-F.;Chang, W.-T.;Yeh, T.-K.;Ou, L.-C.;Chuang, J.-Y.;Tsu-An, Hsu J.;Tao, P.-L.;Loh, H.H.;Shih, C.;Ueng, S.-H.;Yeh, S.-H. |
| 國家衛生研究院 |
2019-12 |
Identification of a multitargeted tyrosine kinase inhibitor for the treatment of gastrointestinal stromal tumors and acute myeloid leukemia
|
Lin, WH;Wu, SY;Yeh, TK;Chen, CT;Song, JS;Shiao, HY;Kuo, CC;Hsu, T;Lu, CT;Wang, PC;Wu, TS;Peng, YH;Lin, HY;Chen, CP;Weng, YL;Kung, FC;Wu, MH;Su, YC;Huang, KW;Chou, LH;Hsueh, CC;Yen, KJ;Kuo, PC;Huang, CL;Chen, LT;Shih, C;Tsai, HJ;Jiaang, WT |
| 國家衛生研究院 |
2019-07-11 |
Linker optimization and therapeutic evaluation of phosphatidylserine-targeting zinc dipicolylamine-based drug conjugates
|
Liu, YW;Chen, YY;Hsu, CY;Chiu, TY;Liu, KL;Lo, CF;Fang, MY;Huang, YC;Yeh, TK;Pak, KY;Gray, BD;Hsu, TA;Huang, KH;Shih, C;Shia, KS;Chen, CT;Tsou, LK |
| 國家衛生研究院 |
2019-07-03 |
BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine
|
Chao, PK;Chang, HF;Chang, WT;Yeh, TK;Ou, LC;Chuang, JY;Tsu-An Hsu, J;Tao, PL;Loh, HH;Shih, C;Ueng, SH;Yeh, SH |
| 國家衛生研究院 |
2019-07 |
Use of integrated genomic analyses in patient-derived tumor model to discover new clinical indications for the multikinase inhibitor drug candidate, DBPR216
|
Kuo, CC;Jiaang, WT;Ou, JJ;Chen, CT;Hsu, SC;Shih, C;Lin, LM;Sun, M;Wang, YH;Huang, ZT;Chang, JY;Ueng, SH |
| 國家衛生研究院 |
2019-07 |
An Aurora kinase inhibitor BPR6K471 inhibits tumor growth and reduces the cancer stem cell-like properties of small cell lung cancer
|
Chang, CP;Ke, YY;Lin, WH;Jhuo, DH;Wang, WP;Tsai, CH;Chen, YT;Su, YJ;Hung, MC;Wu, ZW;Kuo, PC;Yeh, TK;Chen, CP;Song, JS;Chen, CT;Shih, C;Chi, YH |
| 國家衛生研究院 |
2019-05-28 |
Aminothiazole compounds as protein kinase inhibitors
|
Jiaang, WT;Shih, C;Tsai, HJ |
| 國家衛生研究院 |
2019-04-01 |
The in vivo antinociceptive and mu-opioid receptor activating effects of the combination of N-phenyl-2′,4′-dimethyl-4,5′-bi-1,3-thiazol-2-amines and naloxone
|
Lin, SY;Kuo, YH;Tien, YW;Ke, YY;Chang, WT;Chang, HF;Ou, LC;Law, PY;Xi, JH;Tao, PL;Loh, HH;Chao, YS;Shih, C;Chen, CT;Yeh, SH;Ueng, SH |
| 國立成功大學 |
2019 |
The in vivo antinociceptive and μ-opioid receptor activating effects of the combination of N-phenyl-2′,4′-dimethyl-4,5′-bi-1,3-thiazol-2-amines and naloxone
|
Lin, S.-Y.;Kuo, Y.-H.;Tien, Y.-W.;Ke, Y.-Y.;Chang, W.-T.;Chang, H.-F.;Ou, L.-C.;Law, P.-Y.;Xi, J.-H.;Tao, P.-L.;Loh, H.H.;Chao, Y.-S.;Shih, C.;Chen, Chen C.-T.;Yeh, S.-H.;Ueng, S.-H. |
| 國家衛生研究院 |
2018-12 |
Targeting RSPO3 reduces stem cell function in RSPO3-Fusion-positive colon cancer and RSPO3 high lung cancer
|
Hung, HC;Yen, WC;Chang, TY;Yen, GJ;Huang, CT;Fang, MY;Lai, YL;Tsai, YR;Chen, CT;Shih, C;Hsu, TA |
| 臺大學術典藏 |
2018-09-10T15:23:09Z |
A Fully Integrated Nose-on-a-Chip for Rapid Diagnosis of Ventilator-Associated Pneumonia
|
Wang, J.; Chang, K.; Chang, T.; Wang, C.; Chang, C.; Tang, C.; Chen, C.; Shih, C.; Kuo, H.; Wang, L.; Chen, H.; Hsieh, C.; Chang, M.; Liu, Y.; Chen, T.; Yang, C.; Chiueh, H.; Shyu, J.; Tang, K.; Chiu, S.; CHIA-HSIANG YANG et al. |
| 國家衛生研究院 |
2018-06 |
Adding a C-terminal Cysteine (CTC) can enhance the bactericidal activity of three different Antimicrobial Peptides
|
Chen, HL;Su, PY;Kuo, SC;Lauderdale, TLY;Shih, C |
| 國家衛生研究院 |
2018-05-10 |
Design and synthesis of BPR1K653 derivatives targeting the back pocket of Aurora kinases for selective isoform inhibition
|
Ke, YY;Chang, CP;Lin, WH;Tsai, CH;Chiu, IC;Wang, WP;Wang, PC;Chen, PY;Lin, WH;Chang, CF;Kuo, PC;Song, JS;Shih, C;Hsieh, HP;Chi, YH |
| 國家衛生研究院 |
2018-04 |
4-Bromophenylhydrazinyl benzenesulfonylphenylureas as indoleamine 2,3-dioxygenase inhibitors with in vivo target inhibition and anti-tumor efficacy
|
Lin, SY;Yeh, TK;Song, JS;Hung, MS;Cheng, MF;Liao, FY;Li, AS;Cheng, SY;Lin, LM;Chiu, CH;Wu, MH;Lin, YJ;Hsiao, W;Sun, M;Wang, YH;Huang, CH;Tang, YC;Chang, HH;Huang, ZT;Chao, YS;Shih, C;Pan, SL;Wu, SY;Kuo, CC;Ueng, SH |
| 國立成功大學 |
2018 |
4-Bromophenylhydrazinyl benzenesulfonylphenylureas as indoleamine 2,3-dioxygenase inhibitors with in vivo target inhibition and anti-tumor efficacy
|
Lin, S.-Y.;Yeh, T.-K.;Song, J.-S.;Hung, M.-S.;Cheng, M.-F.;Liao, F.-Y.;Li, A.-S.;Cheng, S.-Y.;Lin, Lin L.-M.;Chiu, Chiu C.-H.;Wu, M.-H.;Lin, Y.-J.;Hsiao, W.;Sun, M.;Wang, Y.-H.;Huang, C.-H.;Tang, Y.-C.;Chang, H.-H.;Huang, Z.-T.;Chao, Y.-S.;Shih, C.;Pan, S.-L.;Wu, S.-Y.;Kuo, C.-C.;Ueng, S.-H. |
| 國立成功大學 |
2018 |
Prostaglandin E2receptor 2 modulates macrophage activity for cardiac repair
|
Wu, J.M.F.;Cheng, Y.-Y.;Tang, Tang T.W.H.;Shih, C.;Chen, J.-H.;Hsieh, P.C.H. |
| 國家衛生研究院 |
2017-07 |
Design, synthesis, and evaluation of thiazolidine-2,4-dione derivatives as a novel class of glutaminase inhibitors
|
Yeh, TK;Kuo, CC;Lee, YZ;Ke, YY;Chu, KF;Hsu, HY;Chang, HY;Liu, YW;Song, JS;Yang, CW;Lin, LM;Sun, MW;Wu, SH;Kuo, PC;Shih, C;Chen, CT;Tsou, LK;Lee, SJ |
| 國家衛生研究院 |
2017-06-22 |
Targeting coronaviral replication and cellular JAK2 mediated dominant NF-kappaB activation for comprehensive and ultimate inhibition of coronaviral activity
|
Yang, CW;Lee, YZ;Hsu, HY;Shih, C;Chao, YS;Chang, HY;Lee, SJ |
| 國家衛生研究院 |
2017-05 |
1-(2,4-Dibromophenyl)-3,6,6-trimethyl-1,5,6,7-tetrahydro-4H-indazol-4-one: A novel opioid receptor agonist with less accompanying gastrointestinal dysfunction than morphine
|
Chao, PK;Ueng, SH;Ou, LC;Yeh, TK;Chang, WT;Chang, HF;Chen, SC;Tao, PL;Law, PY;Loh, HH;Cheng, MF;Chuang, JY;Chen, CT;Shih, C;Yeh, SH |
| 國家衛生研究院 |
2017-01-31 |
SkinSensDB: A curated database for skin sensitization assays
|
Wang, CC;Lin, YC;Wang, SS;Shih, C;Lin, YH;Tung, CW |
| 國家衛生研究院 |
2017-01 |
Discovery, structure-activity relationship studies, and anti-nociceptive effects of N-(1,2,3,4-tetrahydro-1-isoquinolinylmethyl)benzamides as novel opioid receptor agonists
|
Chen, SR;Ke, YY;Yeh, TK;Lin, SY;Ou, LC;Chen, SC;Chang, WT;Chang, HF;Wu, ZH;Hsieh, CC;Law, PY;Loh, HH;Shih, C;Lai, YK;Yeh, SH;Ueng, SH |
| 國家衛生研究院 |
2016-12 |
Discovery of BPR1K871, a quinazoline based, multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluation
|
Chang Hsu, Y;Selvaraj Coumar, M;Wang, WC;Shiao, HY;Ke, YY;Lin, WH;Kuo, CC;Chang, CW;Kuo, FM;Chen, PY;Wang, SY;Li, AS;Chen, CH;Kuo, PC;Chen, CP;Wu, MH;Huang, CL;Yen, KJ;Chang, YI;Hsu, JT;Chen, CT;Yeh, TK;Song, JS;Shih, C;Hsieh, HP |
| 國家衛生研究院 |
2016-12 |
Phenyl benzenesulfonylhydrazides: Selective indoleamine 2,3-dioxygenase inhibitors with potent in vivo pharmacodynamic activity and antitumor efficacy
|
Ueng, SH;Yeh, TK;Song, JS;Wu, SY;Kuo, CC;Shih, C;Pan, SL;Hung, MS |
| 國家衛生研究院 |
2016-04-12 |
Pyrazolylamine derivatives reveal the conformational switching between type I and type II binding modes of Anaplastic Lymphoma Kinase (ALK)
|
Tu, CH;Lin, WH;Peng, YH;Hsu, T;Wu, JS;Chang, CY;Lu, CT;Lyu, PC;Shih, C;Jiaang, WT;Wu, SY |
| 國家衛生研究院 |
2016-01 |
Important hydrogen bond networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) inhibitor design revealed by crystal structures of imidazoleisoindole derivatives with IDO1
|
Peng, YH;Ueng, SH;Tseng, CT;Hung, MS;Song, JS;Wu, JS;Liao, FY;Fan, YS;Wu, MH;Hsiao, WC;Hsueh, CC;Lin, SY;Cheng, CY;Tu, CH;Lee, LC;Cheng, MF;Shia, KS;Shih, C;Wu, SY |
| 國家衛生研究院 |
2016-01 |
Phenyl benzenesulfonylhydrazides exhibit selective Indoleamine 2,3-Dioxygenase inhibition with potent in vivo pharmacodynamic activity and antitumor efficacy
|
Lin, SY;Yeh, TK;Kuo, CC;Song, JS;Cheng, MF;Liao, FY;Chao, MW;Huang, HL;Chen, YL;Yang, CY;Wu, MH;Hsieh, CL;Hsiao, WC;Peng, YH;Wu, JS;Lin, LM;Sun, MW;Chao, YS;Shih, C;Wu, SY;Pan, SL;Hung, MS;Ueng, SH |
| 國家衛生研究院 |
2015-12 |
Novel oxime-bearing coumarin derivatives act as potent Nrf2/ARE activators in vitro and in mouse model
|
Chang, KM;Chen, HH;Wang, TC;Chen, IL;Chen, YT;Yang, SC;Chen, YL;Chang, HH;Huang, CH;Chang, JY;Shih, C;Kuo, CC;Tzeng, CC |
| 國家衛生研究院 |
2015-10 |
Identification of substituted naphthotriazolediones as novel tryptophan 2,3-dioxygenase (TDO) inhibitors through structure-based virtual screening
|
Wu, JS;Lin, SY;Liao, FY;Hsiao, WC;Lee, LC;Peng, YH;Hsieh, CL;Wu, MH;Song, JS;Yueh, A;Chen, CH;Yeh, SH;Liu, CY;Lin, SY;Yeh, TK;Hsu, JT;Shih, C;Ueng, SH;Hung, MS;Wu, SY |
| 國家衛生研究院 |
2015-08 |
Novel Nrf2/ARE activator, trans-coniferylaldehyde, induces a HO-1-mediated defense mechanism through a dual p38alpha/MAPKAPK-2 and PK-N3 signaling pathway
|
Chen, HH;Wang, TC;Lee, YC;Shen, PT;Chang, JY;Yeh, TK;Huang, CH;Chang, HH;Cheng, SY;Lin, CY;Shih, C;Chen, CT;Liu, WM;Chen, CH;Kuo, CC |
Showing items 41-90 of 117 (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page
|
